AnorMED Inc. — Investor Relations & Filings
AnorMED Inc. was a chemistry-based biopharmaceutical company focused on the discovery, research, and development of small molecule therapeutics. The company specialized in applying chemistry, biochemistry, and biology to create novel treatments, primarily targeting serious diseases such as cancer and HIV. A key compound in its portfolio, AMD-3100, reached Phase III clinical development. AnorMED Inc. ceased independent operations in October 2006 following its acquisition by Genzyme Corporation for approximately US$584 million.
Recent filings
No filings indexed yet
We are still gathering filings for AnorMED Inc.. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
EdgeLab S.p.A.
Designs and manufactures marine and underwater solutions, i…
|
ELB | IT | Professional, scientific and te… |
|
Editas Medicine, Inc.
A clinical-stage genome editing company developing CRISPR m…
|
EDIT | US | Professional, scientific and te… |
|
EGF Theramed Health Corp.
Developing psychedelic drugs for mental health, diagnostic …
|
TMED | CA | Professional, scientific and te… |
|
Eikon Therapeutics, Inc.
Integrates live-cell imaging and computing to discover ther…
|
EIKN | US | Professional, scientific and te… |
|
Eledon Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for organ and a…
|
ELDN | US | Professional, scientific and te… |
|
Elicera Therapeutics AB
Clinical-stage immuno-oncology company developing cell and …
|
ELIC | SE | Professional, scientific and te… |
|
Elicio Therapeutics, Inc.
Clinical-stage biotech developing lymph node-targeted immun…
|
ELTX | US | Professional, scientific and te… |
|
EMYRIA LIMITED
Clinical-stage biotech developing mental health and neurolo…
|
EMD | AU | Professional, scientific and te… |
|
Energenesis Biomedical CO.,LTD.
Develops small molecule drugs for cellular energy regulatio…
|
6657 | TW | Professional, scientific and te… |
|
Enertopia
Energy solutions company developing patented green technolo…
|
ENRT | CA | Professional, scientific and te… |
AnorMED Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44676/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44676 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44676 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44676 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44676}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AnorMED Inc. (id: 44676)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.